HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Guang Yao Selected Research

Aflatoxin B1 (Aflatoxin B)

6/2018Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1.
10/2017Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1.
2/2016Polymorphisms of a Disintegrin and Metalloproteinase with Thrombospondin Motifs 5 and Aflatoxin B1-Related Hepatocellular Carcinoma.
1/2016Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.
1/2014MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.
1/2014Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.
9/2013Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
7/2013Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma.
11/2011DNA repair gene XRCC7 polymorphisms (rs#7003908 and rs#10109984) and hepatocellular carcinoma related to AFB1 exposure among Guangxi population, China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Guang Yao Research Topics

Disease

11Hepatocellular Carcinoma (Hepatoma)
12/2019 - 11/2011
7Neoplasms (Cancer)
10/2018 - 02/2008
2Liver Diseases (Liver Disease)
01/2016 - 09/2013
2Carcinogenesis
01/2014 - 01/2014
1Fibrosis (Cirrhosis)
06/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
06/2018
1Liver Neoplasms (Liver Cancer)
09/2013
1Infections
12/2011
1Adenocarcinoma
12/2011
1Mouth Neoplasms (Oral Cancer)
02/2008

Drug/Important Bio-Agent (IBA)

9Aflatoxin B1 (Aflatoxin B)IBA
06/2018 - 11/2011
6AflatoxinsIBA
02/2016 - 01/2013
4MicroRNAs (MicroRNA)IBA
10/2017 - 01/2013
3Biomarkers (Surrogate Marker)IBA
10/2018 - 02/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 10/2016
2Metalloproteases (Metalloproteinases)IBA
12/2019 - 02/2016
2ThrombospondinsIBA
12/2019 - 02/2016
2DisintegrinsIBA
12/2019 - 02/2016
2Pharmaceutical PreparationsIBA
10/2018 - 10/2017
2Codon (Codons)IBA
09/2013 - 12/2011
1Ataxin-3IBA
06/2018
1Messenger RNA (mRNA)IBA
06/2018
1CarcinogensIBA
01/2014
1CytokinesIBA
02/2008
1Interleukin-10 (Interleukin 10)IBA
02/2008

Therapy/Procedure

1Therapeutics
10/2018